FR2619220B1 - Antigenes specifiques de leishmania et leur procede de preparation, profils antigeniques contenant ces antigenes et leur application au diagnostic des leishmanioses viscerales. - Google Patents

Antigenes specifiques de leishmania et leur procede de preparation, profils antigeniques contenant ces antigenes et leur application au diagnostic des leishmanioses viscerales.

Info

Publication number
FR2619220B1
FR2619220B1 FR8710979A FR8710979A FR2619220B1 FR 2619220 B1 FR2619220 B1 FR 2619220B1 FR 8710979 A FR8710979 A FR 8710979A FR 8710979 A FR8710979 A FR 8710979A FR 2619220 B1 FR2619220 B1 FR 2619220B1
Authority
FR
France
Prior art keywords
antigens
leishmanioses
leishmania
visceral
diagnosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR8710979A
Other languages
English (en)
Other versions
FR2619220A1 (fr
Inventor
Armand Berneman
Xavier Rolland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
COMPIEGNE UNIVERSITE
Virbac SA
Institut Pasteur de Lille
Original Assignee
COMPIEGNE UNIVERSITE
Virbac SA
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by COMPIEGNE UNIVERSITE, Virbac SA, Institut Pasteur de Lille filed Critical COMPIEGNE UNIVERSITE
Priority to FR8710979A priority Critical patent/FR2619220B1/fr
Priority to PCT/FR1988/000400 priority patent/WO1989001045A1/fr
Publication of FR2619220A1 publication Critical patent/FR2619220A1/fr
Application granted granted Critical
Publication of FR2619220B1 publication Critical patent/FR2619220B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR8710979A 1987-08-03 1987-08-03 Antigenes specifiques de leishmania et leur procede de preparation, profils antigeniques contenant ces antigenes et leur application au diagnostic des leishmanioses viscerales. Expired - Fee Related FR2619220B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR8710979A FR2619220B1 (fr) 1987-08-03 1987-08-03 Antigenes specifiques de leishmania et leur procede de preparation, profils antigeniques contenant ces antigenes et leur application au diagnostic des leishmanioses viscerales.
PCT/FR1988/000400 WO1989001045A1 (fr) 1987-08-03 1988-08-02 Antigenes specifiques de leishmania et leur procede de preparation, profils antigeniques contenant ces antigenes et leur application au diagnostic des leishmanioses viscerales

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8710979A FR2619220B1 (fr) 1987-08-03 1987-08-03 Antigenes specifiques de leishmania et leur procede de preparation, profils antigeniques contenant ces antigenes et leur application au diagnostic des leishmanioses viscerales.

Publications (2)

Publication Number Publication Date
FR2619220A1 FR2619220A1 (fr) 1989-02-10
FR2619220B1 true FR2619220B1 (fr) 1993-03-26

Family

ID=9353819

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8710979A Expired - Fee Related FR2619220B1 (fr) 1987-08-03 1987-08-03 Antigenes specifiques de leishmania et leur procede de preparation, profils antigeniques contenant ces antigenes et leur application au diagnostic des leishmanioses viscerales.

Country Status (2)

Country Link
FR (1) FR2619220B1 (fr)
WO (1) WO1989001045A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL82740A0 (en) * 1987-06-01 1987-12-20 Yeda Res & Dev Assay for leishmaniasis
US5411865A (en) * 1993-01-15 1995-05-02 Iasys Corporation Method of detecting anti-leishmania parasite antibodies
US5912166A (en) * 1995-04-21 1999-06-15 Corixa Corporation Compounds and methods for diagnosis of leishmaniasis
US5965142A (en) * 1995-08-04 1999-10-12 Corixa Corporation Polypeptides and methods for the detection of L. tropica infection
WO1999005528A1 (fr) * 1997-07-28 1999-02-04 Immunetics ANALYSE ET DISPOSITIF PERMETTANT D'IDENTIFIER UNE INFECTION A $i(TRYPANOSOMA CRUZI)
US6673351B1 (en) 2001-03-16 2004-01-06 Astralis, Llc Compositions and methods for the treatment and clinical remission of psoriasis
WO2006079565A2 (fr) * 2005-01-25 2006-08-03 Institut Pasteur Antigenes de leishmania convenant a un kit de diagnostic de leishmania
BRPI0913972B1 (pt) 2008-07-03 2018-06-26 Infectious Disease Research Institute Polipeptídeo de fusão compreendendo antígenos de leishmania, polinucleotídeo, composição farmacêutica, bem como métodos para detecção de infecção e para identificação de leishmaniose e kit diagnóstico para detecção e identificação de leishmaniose

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1983001785A1 (fr) * 1981-11-17 1983-05-26 Brigham & Womens Hospital Anticorps monoclonaux contre le leishmania
EP0197062B1 (fr) * 1984-10-01 1991-01-09 Institut Pasteur Anticorps monoclonaux anti-leishmania, hybridomes secreteurs de ces anticorps, antigenes de leishmania reconnus par ces anticorps, procede d'obtention et applications de ces anticorps monoclonaux et de ces antigenes

Also Published As

Publication number Publication date
WO1989001045A1 (fr) 1989-02-09
FR2619220A1 (fr) 1989-02-10

Similar Documents

Publication Publication Date Title
FR2483912B1 (fr) Derives hydroxycarboxyles du compose ml-236b, leur procede de preparation et leur application therapeutique
BE892758A (fr) Derives phenylcyclobutyliques, leur procede de preparation et leur application therapeutique
FR2504920B1 (fr) Derives phenylcyclobutyliques, leur procede de preparation et leur application therapeutique
BE892270A (fr) Nouveaux derives aminomethyl-5 oxazolidiniques, leur procede de preparation et leur application en therapeutique
OA08652A (fr) Compositions, vaccin et anticorps monoclonaux utiles pour le traitement des affections par le virus HIV et procédés de production de ces anticorps et de diagnostic de la présence de ce virus.
BE888396A (fr) Capsules diagnostiques et therapeutiques et leur preparation,
IL81370A (en) Pharmaceutical and diagnostic compositions comprising a plurality of human monoclonal antibodies for the treatment of bacterial diseases,methods for the preparation of the compositions and antibodies and kits containing said compositions
FR2619220B1 (fr) Antigenes specifiques de leishmania et leur procede de preparation, profils antigeniques contenant ces antigenes et leur application au diagnostic des leishmanioses viscerales.
DE3781652D1 (de) Zubereitung, geeignet fuer die behandlung von darmstoerungen.
FR2506306B1 (fr) Nouveaux derives de l'amidinopiperidine, leur procede de preparation et leur application en therapeutique
BE887324A (fr) Procede de preparation de la relaxine humaine
DE3685917D1 (de) Peptid-zusammensetzung fuer die herstellung von malaria-impfstoff, sowie fuer die vorbereitung von diagnostischen einzelteilen fuer den nachweis von malaria-aehnlichen krankheiten.
BE858356A (fr) Derives d'acide 7-acylamino-8-oxo-3-oxa-1-azabicyclo-(4.2.0)octane-2-carboxylique, leur procede de preparation et leur application en therapeutique
IT8423926A0 (it) Metodo diagnostico per la valutazione di parametri clinici mediante prelievo diretto dimateriali biologici e dispositivoper la sua attuazione.
FI885806A (fi) Polypeptider av stvl-iii-typ, diagnostiska system och analysfoerfarande.
NL188185B (nl) Werkwijze voor de bereiding van immunobiologische preparaten voor de diagnose, profylaxe en/of behandeling van candidainfecties, alsmede werkwijze voor de bereiding van een serum.
IT1198233B (it) Metodo per la determinazione di anticorpi antisporozoita di p. falciparum nel sangue umano
IT1216141B (it) Composizione cosmetica rigenerante la pelle e procedimento per la sua preparazione.
IT7922675A0 (it) Metodo per ridurre la concentrazione di lipidi nel sangue.
FR2547301B1 (fr) Nouveaux composes indoanilines ou indophenols, leur procede de preparation, compositions de teinture les contenant et procede de teinture de cheveux correspondant
PT77767A (fr) Procede de preparation de 3',5'-diarabinosides et de compositi-ons pharmaceutiques les contenant
FR2551440B1 (fr) Aminocyclopentanes, leur procede de preparation et compositions pharmaceutiques les contenant
IT8248451A0 (it) N-/-(3-amminopropil) amminobutil/2,2-diidrossietanammide come immuno stimolante ed intermedio per la produzione di sostanza carcinostatiche, e procedimento per la sua preparazione
ATE71299T1 (de) Pharmazeutische zubereitung zur behandlung bakterieller infektionen.
IT8722055A0 (it) Procedimento per la preparazione di idantoine 5-ariliden e alchilidensostituite.

Legal Events

Date Code Title Description
ST Notification of lapse